A, B Lymphocyte markers (CD3 and CD20) on the skin of individuals... | Download Scientific Diagram
Therapeutic Targeting of B Cells for Rheumatic Autoimmune Diseases | Pharmacological Reviews
Alexa Fluor 700 Anti-Human CD20, B-Ly1 | SouthernBiotech
CD20 expression by IHC and FCM of representative "dim" CD20 and... | Download Scientific Diagram
Anti-CD20/CD3 TDB is potent in killing human lymphoma B cell lines and... | Download Scientific Diagram
Characterization of the canine CD20 as a therapeutic target for comparative passive immunotherapy | Scientific Reports
Trispecific CD19-CD20-CD22–targeting duoCAR-T cells eliminate antigen-heterogeneous B cell tumors in preclinical models | Science Translational Medicine
Targeting CD20 and CD3, the witness and creator in the process of antibody drug development - ACROBiosystems
Detection of subsets of CD3+CD20+ T cells in healthy subjects. (A) (i)... | Download Scientific Diagram
Detection of subsets of CD3+CD20+ T cells in healthy subjects. (A) (i)... | Download Scientific Diagram
B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome | Nature Reviews Clinical Oncology
The regulation and function of CD20: an “enigma” of B-cell biology and targeted therapy | Haematologica
A novel, native-format bispecific antibody triggering T-cell killing of B-cells is robustly active in mouse tumor models and cynomolgus monkeys | Scientific Reports
CD20-positive T-cell lymphoma involving bone marrow: report of four cases | SpringerLink
B cell depletion therapies in autoimmune disease: advances and mechanistic insights | Nature Reviews Drug Discovery
IJMS | Free Full-Text | Promising Immunotherapeutic Modalities for B-Cell Lymphoproliferative Disorders
Antibody drug development: Targeting CD20 and CD3
APC/CY7 Anti-Human CD20, B-Ly1 | SouthernBiotech
DuoBody-CD3xCD20 induces potent T-cell-mediated killing of malignant B cells in preclinical models and provides opportunities for subcutaneous dosing - eBioMedicine
Animals | Free Full-Text | Co-Expression of T- and B-Cell Markers in a Canine Intestinal Lymphoma: A Case Report
Cells | Free Full-Text | Ocrelizumab Depletes CD20+ T Cells in Multiple Sclerosis Patients
Frontiers | Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?
Flow cytometric classification of CD20 levels. a Negative, no... | Download Scientific Diagram
